Hypoxia-induced signaling is important for normal and malignant hematopoiesis. The transcription factor hypoxia-inducible factor-1α (HIF-1α) has a crucial role in quiescence and self-renewal of hematopoietic stem cells (HSCs), as well as leukemia-initiating cells (LICs) of acute myeloid leukemia and chronic myeloid leukemia. We have investigated the effect of HIF-1α loss on the phenotype and biology of FLT-3 ITD -induced myeloproliferative neoplasm (MPN). Using transgenic mouse models, we show that deletion of HIF-1α leads to an enhanced MPN phenotype reflected by an increased number of white blood cells, more severe splenomegaly and decreased survival. The proliferative effect of HIF-1α loss is cell intrinsic as shown by transplantation into recipient mice. HSC loss and organ-specific changes in the number and percentage of long-term HSCs were the most pronounced effects on a cellular level after HIF-1α deletion. Furthermore, we found a metabolic hyperactivation of malignant cells in the spleen upon loss of HIF-1α. Some of our findings are in contrary to what has been previously described for the role of HIF-1α in other myeloid hematologic malignancies and question the potential of HIF-1α as a therapeutic target.
INTRODUCTION
Hypoxia has been proposed to be a physiologic condition in the adult hematopoietic stem cell (HSC) niche and previous publications have provided experimental evidence for this hypothesis. 1 Additionally, it has been shown that hypoxia signaling, through hypoxia-inducible factors (HIFs), is required for proper HSC function, and that this might be mediated by HIF-induced pyruvate dehydrogenase kinase and vascular endothelial growth factor expression. [2] [3] [4] Further dissection of the HIF signaling pathway has indicated that HIF-1α, but not HIF-2α, seems to be the major player in HSC self-renewal. 5 Interestingly, deletion of both members of the HIF family had surprisingly little effect on hematopoiesis in steady state and functional HSC defects were only apparent after serial transplantations. 5 Normally, HIF-1α activity is regulated on a posttranscriptional, posttranslational level by oxygen-dependent hydroxylation of two proline residues in the oxygen-dependent domain of the HIF-1α subunit followed by binding of the von Hippel Lindau protein and degradation by the ubiquitination pathway. 6 Mechanisms other than oxygen tension might regulate HIF-1α expression in the HSC niche. Cytokines, such as stem cell factor and thrombopoietin, that are highly expressed in the adult bone marrow (BM) niche have been shown to lead to HIF-1α stabilization. 7, 8 Moreover, the homeobox gene Meis1 that is highly expressed in HSCs also stabilizes HIF-1α contributing to the quiescence of HSCs. 9 Members of the HIF family have been proposed to be crucial for self-renewal of human acute myeloid leukemia-initiating cells (AML-ICs). Short hairpin RNA (shRNA) expression against HIF-1/2α in human AMLs showed impaired engraftment in nonobese diabetic/severe-combined immunodeficiency mice. 10, 11 Whether HIF was a direct target of the genetic alterations in the used AML samples has not been addressed in these studies. On the other hand, Meis1, commonly overexpressed in AML, induces HIF-1α stabilization, and accordingly, its deletion in transgenic mice leads to HSC exhaustion because of their inability to upregulate HIF-1α. 9, 12 Additionally, it has been shown that the t(9;21) fusion protein BCR-ABL signals directly to HIF-1α leading to its activation. 13 Deletion of HIF-1α in a murine model of chronic myeloid leukemia (CML) showed that CML-initiating cells (CML-ICs) lacking HIF-1α failed to generate leukemia in secondary transplanted mice arguing for an important role of HIF-1α in CML-IC self-renewal. 14 Taking all these data into consideration, HIF-1α might be a good therapeutic target for different types of leukemia if HSCs and leukemic-initiating cells (LICs) had a different requirement for HIF signaling. As previous studies have used methods (shRNA expression, unspecific inhibitors of HIF in human AML cells or retroviral transduction/transplantation assays) 10, 11 that could bear potential technical problems in the evaluation of LIC self-renewal, we have tested the requirement of HIF-1α in myeloproliferative neoplasms (MPNs) using an FLT-3 ITD transgenic mouse model. Internal tandem duplications (ITDs) in the FLT3 gene are found iñ 25% of AML cases, constitutively activating this receptor and predicting increased relapse rates and reduced overall survival. 15 Here, we show that loss of HIF-1α leads to an enhanced FLT-3 ITD -induced MPN phenotype, indicated by an increased number of white blood cells (WBCs) and myeloid cells, more severe splenomegaly and a shorter survival. The increased proliferation is cell intrinsic and this phenotype is transplantable to primary recipient mice. Our data question the role of HIF-1α as a target to eliminate LICs in MPN and show that loss of HIF-1α can aggravate the disease.
MATERIALS AND METHODS

Transgenic mice
Hif-1α
flox/flox mice 16 were crossed with the interferon-inducible Mx1-Cre mice 17 and with the knock-in Flt-3 ITD mice 18 to generate conditional knockout Hif-1α flox/flox ; Mx1-Cre; Flt-3 ITD/+ mice. All animals were bred and maintained in accordance with Lund University's ethical regulations (Ethical permit M86-12).
Monitoring of mice and BM transplantation assays Leukemia development was analyzed by measuring myeloid cells and total WBCs in the peripheral blood (PB) every 4 weeks. Myeloid cells were analyzed by flow cytometry and WBC counts were determined by a cell counter (KX-21N; Sysmex, Norderstedt Germany).
For HSC transplantation, 8-to 12-week-old B6SJL (CD45.1) recipient mice were lethally irradiated with 900 cGy 4-15 h before transplantation. BM c-kit + cells from donors (CD45.2) were isolated using the MACS magnetic separation system and anti-c-kit magnetic beads (Miltenyi Biotec, Bergisch Gladbach, Germany). A total of 5 × 10 5 c-kit + cells were injected into the tail vein of recipient mice accompanied by 2 × 10 5 freshly isolated total BM supporting cells from B6SJL × C57BL/6J (CD45.1-CD45.2) mice. Donor chimerism and myeloproliferative development were determined after transplantation by PB analysis every 4 weeks.
For the transplantation of the cells kept in vitro, c-kit + cells were cultured in serum-free expansion media (StemCell Technologies, Vancouver, BC, Canada) supplemented with 20 ng/ml murine interleukin-3 (PeproTech, Stockholm, Sweden), 50 ng/ml human interleukin-6 (PeproTech), 50 ng/ml human thrombopoietin (PeproTech) and 50 ng/ml murine stem cell factor (PeproTech) for 48 h before transplant.
Animals that had to be killed because of non-MPN-associated symptoms were excluded from the survival analysis.
Deletion of Hif-1α was verified by polymerase chain reaction analysis of DNA from BM cells of primary animals using the following primers: HIFΔ-forward: 5′-GCAGTTAAGAGCACTAGTTG-3′ and HIFΔ-reverse: 5′-TTGGGG ATGAAAACATCTGC-3′.
Flow cytometry analysis
Expansion of the MPN and engraftment of transplanted cells were monitored by flow cytometry analysis of PB, BM and spleen cells. PB samples were lysed with ammonium chloride (StemCell Technologies) before staining. DAPI (4′,6-diamidino-2-phenylindole) (Sigma-Aldrich, St Louis, MO, USA) or 7-amino-actinomycin D (BD Pharmingen, San Diego, CA, USA) was used to exclude dead cells. For chimerism and lineage analysis, the following antibodies were used: Gr1-PE, -PECy5 (RB6-8C5), Mac1-PE, -PECy5 (M1/70), B220-PE, -APC, -PECy5 (RA3-6B2), CD3-PE, -PECy5 (145-2C11), Ter119-PECy5 (TER-119), CD45.1-PECy7 (A20), Sca-1-BV, -APC (D7), CD48-FITC (HM48-1) and CD150-APC, -PECy7 (TC15-12F12.2) from BioLegend (San Diego, CA, USA) and CD45.2-APCe780 (104) and c-kitAPCe780 (2B8) from eBiosciences (San Diego, CA, USA).
For cell cycle analysis, cells were fixed in 0.4% formaldehyde (Merck, Darmstadt, Germany) and permeabilized with 0.1% Triton X-100 (Sigma-Aldrich). Thereafter, cells were stained with Ki-67-PE (B56) antibody (BD Pharmingen) and DAPI (Sigma-Aldrich). Cellular reactive oxygen species (ROS) production was analyzed using CellROX Deep Red Reagent (Life Technologies, Stockholm, Sweden), mitochondrial ROS production was analyzed using MitoSOX Red mitochondrial superoxide indicator (Life Technologies) at 2 μM concentration, mitochondrial activity was evaluated using MitoTracker Deep Red FM probe (Life Technologies) at 10 nM concentration and apoptosis analysis was performed using the BD Pharmingen PE Annexin Apoptosis Detection Kit (BD Pharmingen), all according to the manufacturer's instructions. Samples were analyzed using a FACSCantoII (BD Biosciences, Stockholm, Sweden) and data were analyzed with the FlowJo software (TreeStar, Ashland, OR, USA).
Histology
For morphological analysis, cells from the BM and spleen were subjected to cytospin preparation onto glass slides and PB smears were stained with May-Grünwald (Merck) and Giemsa (Merck). For microscopic examination, an Olympus IX70 microscope and an Olympus DP72 camera were used (Olympus, Tokyo, Japan).
Statistical analysis
All data are expressed as the mean ± s.e.m. Differences between groups were assessed by unpaired two-tailed Student's t-test. Statistical analysis of survival curves was performed using Mantel-Cox log-rank test. All analyses were performed with Prism software version 6.0 (GraphPad Software, San Diego, CA, USA). Animal cohort size was chosen according to the published literature and our previous studies. As all experiments were performed with mice homogeneous regarding strain and age, no randomization method was used. As this study did not include objective measurements, no blinding was performed. 18 We intended to delete the Hif-1α gene using poly(deoxyinosinic/deoxycytidylic) acid for induction of the Cre recombinase under the control of the Mx1 promoter. However, investigation of untreated mice showed that recombination had occurred spontaneously, probably because of the activation of signaling pathways downstream of the Flt3 receptor, triggering an interferon response and leading to the expression of Cre recombinase ( Figure 1a and Supplementary Figure S1 ). Owing to the very high spontaneous deletion frequency of the floxed HIF-1α gene, none of the mice were treated with poly(deoxyinosinic/deoxycytidylic) acid. When studying cell death of these neoplastic myeloid cells, we observed that loss of HIF-1α leads to a decrease in apoptosis both in the BM and spleen (Figure 2f and g).
RESULTS
Spontaneous deletion of
Our data point to a dual role of HIF-1α loss in the observed phenotype by increasing the percentage of cells in active cycling and at the same time decreasing apoptosis, resulting in an overall more severe MPN phenotype.
Loss of HIF-1α leads to an organ-specific change in stem and progenitor cell numbers It has been previously shown that Flt-3 ITD/+ mice present an expansion of multipotent progenitor cells and a severe decrease in long-term HSCs (LT-HSCs) using either CD48/CD150 (SLAM) or FLT-3/CD34 staining of Lin − , Sca-1 + , c-Kit + (LSK) cells. 15, 19, 20 Having shown that deletion of Hif-1α leads to an enhanced FLT-3 ITD -induced MPN, we wanted to further characterize at which level of the hematopoietic hierarchy the effects occur. For this reason, we analyzed and enumerated different hematopoietic stem and progenitor populations using staining for LSK and SLAM markers. As the expression of FLT-3 ITD leads to an expansion of mature granulocytes in BM resulting in a change of cellular composition, both percentages and total numbers of cells were analyzed (Figures 3a and c and Supplementary Figure S4) . We observed the previously described reduction of LT-HSCs (LSK CD48 − CD150 + ) in FLT-3 ITD -expressing mice compared with wildtype (wt) mice, but even to a bigger extent when Hif-1α was deleted. When comparing BM cells from Hif-1α Δ/Δ mice to controls, we found an expansion of the more mature compartment (LK cells: Lin Hif-1α
Hif-1α Plots represent mean ± s.e.m. Unless otherwise stated, two-tailed Student's t-test was used to assess statistical significance. *P o0.05, **Po 0.01 and ***P o0.001.
Hif-1α
Δ/Δ mice in the LSK population in the spleen (Figure 3d and Supplementary Figure S5) . These results, together with data presented in Figure 2e , n = 8). Plots represent mean ± s.e.m. Two-tailed Student's t-test was used to assess statistical significance. *Po 0.05, **Po 0.01 and ***P o0.001.
HIF-1α in FLT-3
ITD myeloid neoplasia T Velasco-Hernandez et al (20- week-old mice) (n = 3; wt, n = 6). Plots represent mean ± s.e.m. Two-tailed Student's t-test was used to assess statistical significance. *P o0.05, **P o0.01 and ***Po0.001.
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The disease was transplantable, and additionally, the acceleration of the MPN phenotype by loss of HIF-1α was also observed in transplanted mice with Hif-1α Δ/Δ cells, arguing for a cell-intrinsic effect of HIF-1α on FLT-3 ITD -induced MPN (Figure 4a and Supplementary Figure S6) . However, the reduction in LT-HSCs observed in transgenic animals (Supplementary Figure S6f) is more severe in transplanted mice, and accordingly, secondary recipients showed a loss of Hif-1α Δ/Δ donor contribution to PB (Supplementary Figure S7) . The fact that Hif-1α Δ/Δ FLT-3 ITD MPN was transplantable into primary recipients indicates that loss of HIF-1α did not result in a defect in LIC engraftment, although the number of LT-HSCs are severely affected in primary recipients.
Whether the effect in the secondary recipients is because of a loss of LIC self-renewal or a displacement of LT-HSC by expanding multipotent progenitor cells in the BM remains elusive.
Previous studies, investigating the role of HIF-1α in CML, have used a retroviral transduction/transplantation model that requires cycling of the hematopoietic stem and progenitor cells, which is normally induced by in vitro culturing in the presence of cytokines. To test whether these experimental differences could explain the conflicting results between our experiments and previously published data, we cultured c-kit + BM cells in the presence of cytokines, as normally performed when using the transduction/transplantation method, and transplanted afterwards. Log-rank (Mantel-Cox) test was used to assess statistical significance of the survival curve. Plots represent mean ± s.e.m. Unless otherwise stated, two-tailed Student's t-test was used to assess statistical significance. *Po 0.05, **Po0.01 and ***P o0.001.
Mice transplanted with in vitro cultured Hif-1α
Δ/Δ BM cells showed not only a similar phenotype regarding the expansion of myeloid cells over time but also a shorter survival (P = 0.0046) (Figure 4b and Supplementary Figures S8a and b) . Mice transplanted with Hif-1α Δ/Δ cultured BM cells started to die of progressive MPN around week 20, with most of the animals dead by week 40, whereas no animal died in the control group.
To evaluate the level of competition in our transplantation experiments, we calculated the number of LT-HSCs injected in each group. According to the obtained values in Figure 3 of c-kit + cells and LT-HSCs in wt, Hif-1α +/+ and Hif-1α Δ/Δ animals, we estimated that the ratio of competitor:donor cells was 1:3 for Hif-1α Δ/Δ and 1:65 for Hif-1α +/+ cells, respectively. Besides the higher competition in the Hif-1α
Δ/Δ group, we observed similar levels of donor contribution to the myeloid compartment 20 weeks after transplantation (Supplementary Figure S8c) . To analyze donor contribution to the other cell lineages discarding the effect of the percentage variation when one population is highly increased, we calculated donor contribution to each lineage in the total number of cells. We observed equal contribution to the T cells from Hif-1α +/+ and Hif-1α Δ/Δ animals. However, we observed more contribution from Hif-1α Δ/Δ donor cells to myeloid cells and less to B-cell lineage most likely because of the MPN phenotype resulting in an expansion of myeloid cells at the expense of B cells (Supplementary Figure S8d) .
In summary, our data indicate that FLT-3
ITD
-induced MPN is cell intrinsic and transplantable, independently of HIF-1α status. Selfrenewal of LICs was not lost even when cells were cultured in vitro for 48 h before primary transplantations, although LT-HSCs numbers are highly reduced in recipient mice transplanted with Hif-1α
HIF-1α status influences mitochondrial activity and ROS levels in FLT-3 ITD -induced MPN
Mitochondrial respiratory chain constitutes the main intracellular source of ROS in most of the tissues. Because HIF-1α status influences the metabolism of cells, 3 which could affect the malignant properties of the FLT-3 ITD cells, we examined mitochondrial membrane function and levels of ROS of these neoplastic myeloid cells. Two different tests showed an increment of cellular and mitochondrial ROS levels in Hif-1α Δ/Δ mice in the BM and an opposite effect in the spleen (Figures 5a and b) .
According to mitochondrial membrane function, we found three well-defined different populations, named as M1, M2 and M3 (Figure 5c ). Whereas in BM there was an increase in the population with less mitochondrial activity (M1) when Hif-1α is deleted, we observed a reduction of this population in the splenic myeloid cells. This could be indicating that high ROS production is a result of higher mitochondrial function caused by higher metabolic activity of Hif-1α Δ/Δ cells. Taken together, these data could indicate a metabolic adaptation of these malignant cells to their new niches and an improvement of their tumorigenic capacities (less quiescence and more proliferation) when HIF-1α is lost in these cells.
DISCUSSION
Hypoxia signaling, mainly mediated by transcription factors HIF-1α and HIF-2α and their target genes, has been shown to have an important role in stem cell biology, particularly in normal and malignant hematopoietic stem and progenitor cells. Previous work has provided evidence that HIF-1α is required for HSC quiescence and self-renewal, 2 and that HIF-2α has a role in protecting HSCs from endoplasmic reticulum stress-induced apoptosis.
11 Surprisingly, loss of HIF-1α function (and combined loss of HIF-1α and HIF-2α) seems rather weak as the phenotype comes only apparent after challenging HSCs by serial transplantation. 2, 5 Additionally, it has been demonstrated that HIF may have a role in murine and human leukemia. Inhibitors and shRNA against HIF-1α and HIF-2α have been used to show the requirement of these two transcription factors in human AML-IC self-renewal and the ability to induce AML in immunocompromised mice. 10, 11 The concept to target HIF in AML is intriguing but whether there is a therapeutic window for the treatment of leukemia by targeting HIF-1/2α without inducing major hematologic toxicity has not been extensively studied. It also remains elusive whether HIF can function as a therapeutic target for all genetic subtypes of AML. It has been shown that some genetic alterations in AML stabilize HIF in a hypoxia-independent manner, making these specific subtypes prime targets for therapy against HIF. Requirement of HIF-1α for CML-ICs self-renewal has been confirmed using retroviral overexpression of BCR-ABL oncogene in BM cells from HIF-1α conditional knockout mice.
14 All these approaches have some technical caveats that could influence the viability of LICs. First, inhibitors of HIF-1α are rather unselective making it difficult to evaluate whether their effect is primarily caused by HIF-1α inhibition. Expression of shRNA against HIF family members requires retroviral transduction of AML-LICs and might have offtarget effects even though scrambled shRNA was used as the control. Retroviral transduction of BM cells requires cytokine stimulation of hematopoietic stem and progenitor cells in vitro, which can change the properties of these cells. Therefore, we have investigated the role of HIF-1α in FLT-3 ITD -induced MPN using just transgenic mouse models for both genetic alterations.
The first unexpected result was a spontaneous deletion of the floxed Hif-1α gene in Flt-3 ITD ; Mx1-Cre background. We assume that FLT-3 ITD signaling triggers an interferon response that leads to the activation of Cre recombinase via activation of Mx1 promoter. Our finding is in accordance with the published literature 20, 21 in which mice with either Runx1 flox/flox or Npm1
in combination with an Flt-3 ITD and Mx1-Cre genotype develop AML spontaneously.
In contrary to the previously described role of HIFs in LICs of AML and CML, we found that HIF-1α loss exaggerates FLT-3 ITDinduced MPN phenotype, as indicated by a shorter survival, higher number of myeloid cells in PB, BM and spleen, leading to a more severe splenomegaly.
It has been previously shown that Flt-3 ITD knock-in mice have an expansion of the myeloid progenitor compartment, whereas the LT-HSC population was severely decreased. 15, 19, 20 We observed that this effect is even more aggravated when Hif-1α is deleted. Surprisingly, reduction of LT-HSCs was not associated with a marked loss of LIC homeostasis, as the MPN could be transplanted into primary recipient animals even after in vitro incubation. Interestingly, transplanted MPNs lacking HIF-1α showed an even more aggressive phenotype as indicated by a shorter survival of transplanted mice. Whether the reduction in LT-HSCs in the BM of primary recipients and the associated low contribution of Hif-1α Δ/Δ cells in the secondary recipients is because of a defect in selfrenewal or a displacement by progenitors and mature myeloid cells needs further investigation.
Hypoxia-induced HIF expression has been linked to metabolic switch owing to a shift from oxidative phosphorylation to glycolysis, an effect that has been first described by Warburg and carries his name. 22 Tumors that become hypoxic heavily depend on this mechanism, but even tumors that are not hypoxic switch to energetically very inefficient glycolysis for reasons that still remain elusive. Therefore, we investigated the metabolic profile (mitochondrial function and ROS levels) of FLT-3 ITD -MPN cells lacking HIF-1α. It has been described that changes in these parameters can affect self-renewal and differentiation of HSCs. For instance, when mitochondrial potential is blocked, HSCs are unable to initiate differentiation 23 and high levels of ROS force cells to go out of quiescence. 24, 25 We found a correlation between cycling profile, ROS levels and mitochondrial function in FLT-3 ITD -MPN cells HIF-1α in FLT-3 ITD myeloid neoplasia T Velasco-Hernandez et al (Figure 5d ), indicating a more active status of Hif-1α Δ/Δ cells in the spleen, the main (malignant) hematopoietic organ in animals with MPN and leading to a more aggressive disease.
The fact that, in animals with the MPN, hematopoiesis is taking place in an extramedullary niche (spleen), with very different microenvironmental properties from the BM, including oxygen tension, lead us to postulate that these observed differences are established by cell-intrinsic mechanisms that stabilize HIF-1α, imprinted already in the primary niche (BM) or by originating genetic alterations of the malignancy.
These results are in concordance with our recent findings regarding the role of HIF-1α in AML pathogenesis using oncogenes that either do or do not signal directly towards HIF-1α. Expression of MLL-AF9 and MEIS1/HOXA9, which are supposedly activating HIF-1α, and AML1/ETO9a, a truncated version of the AML1/ETO fusion protein with no known connection to HIF-1α, induced AML independent of HIF-1α status. 26 HIF-1α was not needed for LIC self-renewal, but loss of HIF-1α rather lead to an accelerated and more severe phenotype, similar to the observations made for the ITD -induced MPN model described in this paper.
Based on previous studies, it has been proposed that HIF might be used as molecular therapeutic target to interfere with selfrenewal of LICs. Our data indicate that targeting HIF-1α in FLT-3 ITDinduced MPN rather leads to disease acceleration and a more severe phenotype. Whether the inhibition of HIF in combination with chemotherapy or targeted small molecules can be a useful therapeutic strategy needs further investigation. -1α +/+ , n = 8; Hif-1α Δ/Δ , n = 9), in myeloid cells (Gr1 + /Mac1 + ) of the BM and spleen. We observed three different populations according to MitoTracker staining, which we named M1, M2 and M3 from lower to higher intensity. We determined the percentage of myeloid cells in each of these populations (three independent experiments; 20-week-old mice). (d) Summary of the metabolic profile of Hif-1α Δ/Δ and Hif-1α +/+ myeloid cells in the BM and spleen. Dashed lines indicate statistically nonsignificant data. Plots represent mean ± s.e.m. Two-tailed Student's t-test was used to assess statistical significance. *P o 0.05, **P o 0.01 and ***P o 0.001.
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